{"id":"NCT00552344","sponsor":"UCB BIOSCIENCES GmbH","briefTitle":"A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease","officialTitle":"A Phase IIIb, Multinational, Open-label, follow-on Trial to C87085 Designed to Assess the Long-term Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-TNF-alpha Monoclonal Antibody, Administered at Weeks 0, 2 and 4, and Then Every 4 Weeks Thereafter, in Subjects With Moderately to Severely Active Crohn's Disease Who Have Participated in Study C87085","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2007-11-01","resultsPosted":"2016-01-21","lastUpdate":"2018-08-09"},"enrollment":403,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Crohn Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Cimzia","otherNames":["Certolizumab Pegol","CDP870","CZP"]}],"arms":[{"label":"Certolizumab Pegol","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to assess the safety of long term therapy with Certolizumab Pegol in those subjects participating in study C87085 \\[NCT00552058\\].","primaryOutcome":{"measure":"Percentage of Subjects With at Least One Adverse Event (AE) During the Duration of the Study C87088 (up to 272 Weeks)","timeFrame":"From study start to the end of the Safety Follow-up Period (up to 272 weeks)","effectByArm":[{"arm":"Certolizumab Pegol","deltaMin":89.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":100,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","Czechia","Estonia","Germany","Hungary","Israel","Italy","Latvia","New Zealand","Poland","Romania","Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":149,"n":402},"commonTop":["Crohn's disease","Abdominal pain","Upper respiratory tract infection","Diarrhoea","Arthralgia"]}}